166 related articles for article (PubMed ID: 34164954)
1. Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea.
Oh TK; Cho HW; Suh JW; Song IA
Yonsei Med J; 2021 Jul; 62(7):577-583. PubMed ID: 34164954
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
[TBL] [Abstract][Full Text] [Related]
3. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study.
Oh TK; Song IA
BMC Pulm Med; 2021 Jan; 21(1):12. PubMed ID: 33407347
[TBL] [Abstract][Full Text] [Related]
4. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
[TBL] [Abstract][Full Text] [Related]
5. Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19.
Kocayigit I; Kocayigit H; Yaylaci S; Can Y; Erdem AF; Karabay O
Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):71-76. PubMed ID: 32965360
[TBL] [Abstract][Full Text] [Related]
6. Treatment of uncomplicated hypertension is associated with a reduction in cardiovascular mortality: a Korean national cohort study.
Lee CJ; Hwang J; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S
J Hypertens; 2017 May; 35 Suppl 1():S41-S49. PubMed ID: 28350620
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic target and clinical impact of day-to-day blood pressure variability in hypertensive patients with covid-19.
Jagannatha GNP; Yasmin AAADA; Pradnyana IWAS; Kamardi S; Pradnyaandara IGBMA; Pangkahila EE; Perkasa GOBD; Wibawa IBS
Hypertens Res; 2023 Jan; 46(1):165-174. PubMed ID: 36280737
[TBL] [Abstract][Full Text] [Related]
8. Musculoskeletal Disorders, Pain Medication, and in-Hospital Mortality among Patients with COVID-19 in South Korea: A Population-Based Cohort Study.
Oh TK; Song IA; Lee J; Eom W; Jeon YT
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34202825
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea.
You JH; Lee SA; Chun SY; Song SO; Lee BW; Kim DJ; Boyko EJ
Endocrinol Metab (Seoul); 2020 Dec; 35(4):901-908. PubMed ID: 33297603
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis.
Kow CS; Ramachandram DS; Hasan SS
Hypertens Res; 2022 Feb; 45(2):360-363. PubMed ID: 34754084
[TBL] [Abstract][Full Text] [Related]
12. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
13. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
Tardif JC; Ducharme A; Yu H; Wogen J; Guertin MC
Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
15. Calcium-Channel Blockers and Dementia Risk in Older Adults - National Health Insurance Service - Senior Cohort (2002-2013).
Hwang D; Kim S; Choi H; Oh IH; Kim BS; Choi HR; Kim SY; Won CW
Circ J; 2016 Oct; 80(11):2336-2342. PubMed ID: 27666598
[TBL] [Abstract][Full Text] [Related]
16. Use of calcium channel blockers and myocardial infarction in hypertensive patients with rheumatoid arthritis - A nationwide cohort study.
Lin TT; Ko TY; Lin LY; Wu CK
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):350-358. PubMed ID: 31257076
[TBL] [Abstract][Full Text] [Related]
17. Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study.
Lindberg G; Lindblad U; Löw-Larsen B; Merlo J; Melander A; Råstam L
Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):493-7. PubMed ID: 12426934
[TBL] [Abstract][Full Text] [Related]
18. Statin Therapy and the Risk of COVID-19: A Cohort Study of the National Health Insurance Service in South Korea.
Oh TK; Song IA; Jeon YT
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33578937
[TBL] [Abstract][Full Text] [Related]
19. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
Lee SW; Yang JM; Moon SY; Yoo IK; Ha EK; Kim SY; Park UM; Choi S; Lee SH; Ahn YM; Kim JM; Koh HY; Yon DK
Lancet Psychiatry; 2020 Dec; 7(12):1025-1031. PubMed ID: 32950066
[TBL] [Abstract][Full Text] [Related]
20. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
